Medafor Inc. received FDA clearance for its Arista AH absorbable hemostasis powder in September 2006, and the hemostat has compiled a record of success in more than 100,000 surgeries worldwide, raising expectations for its entrance to U.S. medical markets.
Currently, Arista AH is indicated for most surgeries including cardiac, thoracic, orthopedic, spinal and general applications. It is the only new generation surgical hemostat that is instantly ready to use, requiring no mixing, no addition of patient blood or other components and no special handling or storage conditions.
Arista AH is a plant-derived, flowable powder engineered to rapidly dehydrate blood, enhancing clotting on contact. It facilitates the formation of a highly resilient, natural clot within just a few minutes, regardless of the patient's coagulation status. The unique formulation has been shown to provide simpler, faster application and its rapid absorption — within 24 to 48 hours — leads to little risk of associated complications or infection.